Purpose: Oral use is the primary route of administration among non-medical prescription opioid users. While progression to non-oral routes and shifts to stronger opioids have been previously studied as ways to cope with tolerance, the prevalence and patterns of those who cope by increasing the number of pills/tablets ingested at one time (ie, multi-pill use) has not been assessed. Results: Over two-thirds of non-medical prescription opioid users had a history of multi-pill use (67.7%), defined as ingesting four or more of the same pill, intact and at the same time. Among these (n = 154), the median maximum number of pills taken at one time was eight, with over 20% ingesting 11 or more pills in a single instance.
| INTRODUCTION
The United States is in the midst of an opioid epidemic that began in earnest 15-20 years ago, 1 primarily with prescription opioids. Most first time users, between 66% and 97% among various non-medical use populations, initiate such use by swallowing a pill/tablet whole. 2 However, users must eventually determine how to cope with the development of tolerance that is inevitable with the persistent use of any opioid. The literature is primarily devoted to two consequences of tolerance: (1) progressing to non-oral routes of administration such as injection and inhalation, which provide a more rapid response with less drug [2] [3] [4] [5] [6] or (2) shifting to stronger opioids (prescription or illicit) to replace a weaker one to which tolerance has developed. [7] [8] [9] [10] What is often overlooked and little understood is a seemingly obvious third pathway for coping with tolerance: increasing the number of pills/tablets ingested at one time.
This third pathway deserves special consideration for a number of reasons. First, ingestion of multiple opioid pills/tablets at one time could increase the risk for adverse events or overdose. Second, nonmedical oral use is not a primary target of intervention for pharmaceutical companies, who are currently focusing on abuse-deterrent formulations to reduce injection and inhalation of prescription opioids. 9 However, abuse-deterrent formulations can be ingested like any other prescription drug, and so there are no current mechanisms in place to deter the use of multiple abuse-deterrent pills/tablets at one time. Finally, not all non-medical prescription opioid users will advance to non-oral routes of administration, due to fear of adverse events or needles. One recent review indicated rates of non-oral use range from only 0.5% to 15% among various populations using prescription opioids non-medically (excluding recreational college students), suggesting the majority of non-medical users prefer oral routes. 2 For these reasons, it seems quite important to understand the characteristics and outcomes of non-medical oral use at a deeper level. In this study, we have focused on a specific area of nonmedical oral use, the ingestion of multiple opioid pills/tablets at one time (ie, multi-pill use), for which we seek to understand the preva- 
| RAPID data analysis
In order to gather descriptive data on multi-pill ingestion, a series of 
KEY POINTS
• Ingestion of multiple pills at one time is a common form of using prescription opioids for non-medical purposes.
• Accessibility to a high number of low dose pills is a primary motivator of multi-pill use.
• Multi-pill use most often involves immediate-release rather than extended-release opioids.
3 | RESULTS
| Characteristics and patterns of multi-pill users
Over two-thirds of non-medical prescription opioid users in our sample had a history of at least one episode of multi-pill use (67.7%, N = 155 of 229). As shown in but also nearly half of those who were using opioids non-medically in the past month indicated they engaged in multi-pill use more than once a day (43.8%). 
| Motivations for multi-pill use
When asked an open-ended question to explain the decision to swallow multiple pills instead of using fewer pills of a higher dosage, the overwhelming majority (85.4%, n = 187) indicated that "accessibility/availability" drove their decision to swallow multiple pills of the same dosage. To wit,
Only able to obtain a certain mg without paying higher rates. I couldn't get a higher dose from the doctors so I improvised and took more pills to get the desired high I was after.
The three next most popular themes, which were endorsed by less than 10% of the sample, included "better feeling/high" (6.8%, n = 15), "was taking the highest dose" (4.6%, N = 10), and "tolerance" (4.1%, n = 9).
| DISCUSSION
Our results indicate that non-medical, multi-pill opioid use, defined as "4 or more of the same opioid pill taken intact, and at the same time,"
is extremely common among treatment-seeking opioid users, with nearly half of past month multi-pill users ingesting more than once a day. While new users do not generally initiate non-medical use by taking multiple pills/tablets, as tolerance develops, they must find a way to compensate, and multi-pill use appears to be more prevalent than shifts to non-oral use or stronger, higher dosage opioids. 2 While ingestion of multiple pills may seem an obvious form of non-medical use, the high prevalence rate in our sample, the risk of overdose (particularly for those ingesting multiple pills more than once a day), and the fact that oral use makes up the vast majority of calls to poison centers suggest a more critical evaluation of multi-pill use is needed, with future research understanding co-ingestion of multiple types of opioids, or opioids and non-opioids.
While further analysis is needed to understand how much of the overdose burden involves multi-pill use, several implications stand out in terms of prevention: First, development of affordable and effective pill dispensers may be useful for high-risk patients and have been shown to be effective for buprenorphine adherence 13 ; second, due to the large quantities of pills ingested, encouraging greater utilization of prescription monitoring programs or prescribing guidelines could serve to deter access; third, multi-pill use of intact tablets will not be prevented through abuse-deterrent formulations meant to reduce/inhibit non-oral use. Novel "abuse-deterrent formulations"
should be a higher priority in terms of (1) effectively deterring the effects or release of drug from ingesting multiple opioid tablets and (2) immediate-release opioids, which were the most commonly ingested in our sample and which are prescribed at rates that vastly outnumber those for extended-release opioids. Multi-pill ingestion of prescription opioids, along with other forms of non-medical oral use of these drugs (ie, chewing, use of multiple pills of different opioids at the same time, and simultaneous use of oral and non-oral methods) for non-therapeutic purposes warrants further research and investigation, particularly as they are the primary pathway of non-therapeutic use. A greater emphasis should be placed on how multi-pill ingestion plays a role in the opioid epidemic, particularly in prevention and intervention measures, which should take into account this highly prevalent, but little studied alternative method of coping with tolerance.
